Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Organic chemistry Stories

2014-02-20 23:01:06

Antibiotic Allegedly Associated With Severe Nerve and Muscle Problems Dallas, TX (PRWEB) February 20, 2014 Baron and Budd, a national plaintiffs’ law firm, announced today that it is accepting lawsuits against the manufacturers of Levaquin, an antibiotic designed to treat bacterial illnesses and infections. The medication has been allegedly linked to a serious condition known as peripheral neuropathy, which can result in several types of sensory problems such as pain, diminished...

2014-02-20 16:21:16

DUBLIN, February 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6lcmtg/herbicides_china) has announced the addition of the "Latest News from the Chinese Herbicides Industry" [http://www.researchandmarkets.com/research/6lcmtg/herbicides_china ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Herbicide is the best performing sector in domestic pesticide industry this year. According...

2014-02-20 16:21:12

DUBLIN, February 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/f2q9wt/fungicides_china) has announced the addition of the "Latest News on the Chinese Fungicides Industry" [http://www.researchandmarkets.com/research/f2q9wt/fungicides_china ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) In contrast to the situation of insecticides and herbicides which witnessed strong export...

2014-02-20 08:32:05

SEATTLE, WA and BOULDER, CO, Feb. 20, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (NASDAQ: ARRY) today announced the initiation of a Phase 1b trial of ONT-380 (ARRY-380) in combination with Kadcyla® (ado-trastuzumab emtansine or TDM-1) in patients with metastatic HER2+ breast cancer. ONT-380 is an orally active, reversible and selective small-molecule HER2 inhibitor invented by Array and being developed by Oncothyreon in collaboration with Array....

2014-02-20 08:31:56

WAYNE, Pa., Feb. 20, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status for both Egalet-001, an abuse-deterrent, extended-release, oral morphine formulation, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation, both in development for the treatment of moderate to severe pain. http://photos.prnewswire.com/prnvar/20140219/NY67493LOGO FDA's Fast...

2014-02-20 08:31:44

COLUMBIA, S.C., Feb. 20, 2014 /PRNewswire/ -- Lipitor lawsuits filed in federal courts on behalf of people who allegedly developed type 2 diabetes after taking Pfizer's cholesterol-lowering statin, also called atorvastatin, have been consolidated in the District of South Carolina according to a court order filed Feb. 18, (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML)), announced Janet, Jenner & Suggs attorney Kenneth Suggs, who is representing plaintiffs. (Photo:...

2014-02-19 23:28:21

National network of attorneys will continue consumer updates of allegations raised in Australia and maintain offer of complimentary consultations in connection with concerns announced by FDA that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) February 19, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced its latest update over litigation involving the popular anti-cholesterol medication...

2014-02-19 23:27:36

As Reuters reported on February 13, Boehringer faces more than 2,000 US lawsuits claiming that Pradaxa caused severe and fatal bleeding. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects. San Diego, CA (PRWEB) February 19, 2014 AttorneyOne.com, a recognized authority on law, updated the website recently and now, can...

2014-02-19 23:01:46

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly suffer from Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) February 19, 2014 Dozens of federally-filed Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) that allege the statin drug caused patients to develop Type 2 diabetes have been consolidated in a multidistrict litigation and transferred to the U.S. District Court, District of South Carolina, for pretrial proceedings. According...

2014-02-19 16:23:03

DALLAS, Feb. 19, 2014 /PRNewswire-iReach/ -- MarketReportsChina.com adds "Research and Investment Prospect Evaluation of China Polyaniline (PAN) Market, 2014)" and "Production and Market of Azoxystrobin in China Edition (3)" reports to its store. (Photo: http://photos.prnewswire.com/prnh/20140219/MN67752) The global consumption of azoxystrobin was about 4,500 tonnes in 2013, and the production capacity could meet the demand well at present. Europe and America were two large consumers of...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »